Detecting viral tropism: impact of a more sensitive Trofile (ES) assay
30 August 2008. Related: Conference reports, Drug resistance.
Conference reports
Low frequency K103N mutations are associated with poor virological response to NNRTI based therapy
30 August 2008. Related: Conference reports, Drug resistance.
14th Annual BHIVA Conference, 23-25 April 2008, Belfast
30 August 2008. Related: Conference reports.
Bone problems raised in several UK studies
30 August 2008. Related: Conference reports, Side effects.
Late diagnosis in adolescence of vertically acquired HIV infection
30 August 2008. Related: Conference reports, Paediatric care.
Case study of multi-drug resistant woman receiving newer antiretroviral drugs in pregnancy
30 August 2008. Related: Conference reports, Pregnancy.
Predictors of treatment failure in Western Cape, South Africa
30 August 2008. Related: Conference reports.
Late pregnancy loss in HIV-positive women
30 August 2008. Related: Conference reports, Pregnancy.
Renal tubular dysfunction with tenofovir-based HAART in four vertically infected adolescents
30 August 2008. Related: Conference reports, Antiretrovirals.
15th Conference on Retroviruses and Opportunistic Infections, Boston, 2-6 February 2008
30 August 2008. Related: Conference reports.
The unmet need for contraception services for women receiving ART
30 August 2008. Related: Conference reports, Women's health.
Valacyclovir decreases plasma and genital viral loads in HSV-2/HIV-1 co-infected women
30 August 2008. Related: Conference reports, Women's health.
HPV genotypes in HIV-positive women in Zimbabwe and Uganda
30 August 2008. Related: Conference reports, Women's health.
14th Annual BHIVA Conference, 23-25 April 2008, Belfast
12 June 2008. Related: Conference reports.
Overview of MRC studies in 2008
12 June 2008. Related: Conference reports.
Initial results of BHIVA audit of HIV-related inpatient and day care in the UK
12 June 2008. Related: Conference reports.
Monitoring patients on antiretroviral therapy in resource-limited settings with viral load, CD4 count, or clinical observation alone
12 June 2008. Related: Conference reports.
Lower bilirubin increases in HCV-positive patients using atazanavir
12 June 2008. Related: Conference reports.
Cases of ventricular tachycardia and atazanavir/r and methadone
12 June 2008. Related: Conference reports.
Choice of ARVs for people after organ transplantation
12 June 2008. Related: Conference reports.
Use of fibroscan as non-invasive alternative to liver biopsy in HCV/HIV coinfection
12 June 2008. Related: Conference reports, Hepatitis coinfection.
New-fill used to treat lipoatropy in feet
12 June 2008. Related: Conference reports, Side effects, Weight, diabetes, metabolic complications.
Effect of 100mg ritonavir once- and twice-daily on lipids and cardiovascular markers in HIV-negative volunteers
12 June 2008. Related: Conference reports.
15th Conference on Retroviruses and Opportunistic Infections, Boston, 2-6 February 2008
12 June 2008. Related: Conference reports.
Immediate HAART reduces death and AIDS progression over 48 weeks in patients with acute OIs
12 June 2008. Related: Conference reports, Coinfections and complications.
Utility of routine viral load, CD4 count and clinical monitoring among HIV-positive adults in rural Uganda
12 June 2008. Related: Conference reports, Treatment access.
Implementation of more complex regimens for prevention of mother-to-child transmission of HIV in Rwanda
12 June 2008. Related: Conference reports, Treatment access.
The estimated cost of switching from d4T to TDF in South Africa
12 June 2008. Related: Conference reports, Treatment access.
Gender differences in viral load by CD4 count in men and women
12 June 2008. Related: Conference reports, Women's health.
Immune reconstitution inflammatory syndrome in young children initiating ART
12 June 2008. Related: Conference reports, Paediatric care.
Complications with BCG vaccination in HIV-positive and negative infants: CHER Study
12 June 2008. Related: Conference reports, Paediatric care.
The association between clinical characteristics and HIV-infection in very young infants
12 June 2008. Related: Conference reports, Paediatric care.
Safety and efficacy of boosted darunavir in treatment-experienced children and adolescents at 24 weeks
12 June 2008. Related: Conference reports, Paediatric care.
Responses to atazanavir-containing HAART in treatment-naive children in South Africa
12 June 2008. Related: Conference reports, Paediatric care.
Initial growth, CD4, and viral load responses to HAART in Ugandan compared to UK/Irish HIV-positive children
12 June 2008. Related: Conference reports, Paediatric care.
Paediatric pharmacokinetic studies
12 June 2008. Related: Conference reports, Paediatric care.
A pilot study of three treatment strategies for HIV-positive infants
12 June 2008. Related: Conference reports, Paediatric care.
15th Conference on Retroviruses and Opportunistic Infections, 2-6 February 2008, Boston
2 April 2008. Related: Conference reports.
Atazanavir/r vs lopinavir/r in treatment-naive patients: 48 week results
1 April 2008. Related: Conference reports, Antiretrovirals.
Baseline inflammation and coagulation markers and changes over four weeks during a treatment interruption are strongly linked to HIV viraemia and risk of mortality
1 April 2008. Related: Conference reports.
Restarting treatment after an interruption reduces the risk of serious events but CD4 recovery falls short of baseline levels
1 April 2008. Related: Conference reports.
Very low rate of MTCT in women on HAART in UK and Ireland who achieve viral suppression
1 April 2008. Related: Conference reports, Pregnancy.
Predictors of mother to child transmission among women initiating HAART in pregnancy in a South African cohort
1 April 2008. Related: Conference reports, Pregnancy.
Maternal and infant outcomes from the DREAM programme
1 April 2008. Related: Conference reports, Pregnancy.
Nevirapine-resistant HIV present in the latent reservoir following single-dose nevirapine for MTCT prevention
1 April 2008. Related: Conference reports, Pregnancy.
Tenofovir plus FTC reduce NNRTI resistance following single dose nevirapine
1 April 2008. Related: Conference reports, Pregnancy.
Response to treatment after single dose NVP exposure in women
1 April 2008. Related: Conference reports, Pregnancy.
Response to treatment after single dose NVP exposure in infants
1 April 2008. Related: Conference reports, Pregnancy.
Other studies looking at birth outcomes
1 April 2008. Related: Conference reports, Pregnancy.
Infant prophylaxis for postnatal transmission
1 April 2008. Related: Conference reports, Pregnancy.
Antiretroviral drug concentrations in breast milk and breastfeeding infants
1 April 2008. Related: Conference reports, Pregnancy.
Maternal breastfeeding prophylaxis
1 April 2008. Related: Conference reports, Pregnancy.
Risk factors for breastfeeding transmission
1 April 2008. Related: Conference reports, Pregnancy.
UK cohort reports sexual HCV reinfection in at least 5% HIV-positive gay men following sustained response to treatment
1 April 2008. Related: Conference reports, Hepatitis coinfection.
MELD score predictive of pre-transplant mortality in HCV coinfected patients
1 April 2008. Related: Conference reports, Hepatitis coinfection.
Does abacavir decrease SVR rates with HCV treatment?
1 April 2008. Related: Conference reports, Hepatitis coinfection.
No effect of interferon maintenance therapy on fibrosis progression in non-responders
1 April 2008. Related: Conference reports, Hepatitis coinfection.
Stem cell transplant from HLA-matched CCR5-delta 32 deleted donor suppresses viraemia in recipient for 8 months without HAART
1 April 2008. Related: Conference reports, Basic science and immunology.
Risk factors for AIDS-defining and non AIDS-defining cancers
1 April 2008. Related: Conference reports, Cancer and HIV.
CROI 2008 – 12 key areas of research: non-technical summary of 25 studies and presentations
28 February 2008. Related: Special reports, Conference reports.
15th Conference on Retroviruses and Opportunistic Infections, 2-6 February 2008, Boston
1 February 2008. Related: Conference reports.
Increased risk of myocardial infarction associated with abacavir and ddI
1 February 2008. Related: Conference reports.
Position statement by the D:A:D steering committee
1 February 2008. Related: Conference reports.
3rd International Workshop on Targeting HIV Entry, 7-9 December 2007, Washington DC
1 February 2008. Related: Conference reports.
CXCR4-using HIV found in 8.5% during early HIV infection
1 February 2008. Related: Conference reports.